Arany I, Fleischmann C M, Tyring S K, Fleischmann W R
Department of Microbiology and Immunology, The University of Texas Medical Branch, Galveston 77555-1019, USA.
Cancer Lett. 1997 Nov 11;119(2):237-40. doi: 10.1016/s0304-3835(97)00288-7.
Previously we demonstrated that IFN-alpha augments mda-6/WAF1 and inhibits cyclin-dependent kinases in a p53-independent fashion in B 16 murine melanoma cells. On the other hand, IFN-gamma activates p53 expression without affecting the mda-6/WAF1 system. Combination of the two IFNs is additive. B16 cells acquire IFN-alpha resistant but IFN-gamma sensitive phenotype after long term IFN-alpha treatment (B16alpha cells). Here we demonstrate the absence of mda-6/WAF1-associated repression of cyclin-dependent kinases, but the existence of p53-dependent c-myc inhibition in IFN-gamma-treated B16alpha cells. Clearly, selective desensitization of IFN-alpha related growth regulation does not influence the IFN-gamma associated pathway. Our results further support the coexistence of distinct growth regulatory mechanisms in B16 cells that can be activated by different IFN-types independently of each other.
先前我们证明,在B16小鼠黑色素瘤细胞中,干扰素-α(IFN-α)以不依赖p53的方式增强mda-6/WAF1并抑制细胞周期蛋白依赖性激酶。另一方面,干扰素-γ(IFN-γ)激活p53表达而不影响mda-6/WAF1系统。两种干扰素联合使用具有相加作用。长期用IFN-α处理后,B16细胞获得对IFN-α耐药但对IFN-γ敏感的表型(B16α细胞)。在此我们证明,在IFN-γ处理的B16α细胞中不存在mda-6/WAF1相关的细胞周期蛋白依赖性激酶抑制,但存在p53依赖性的c-myc抑制。显然,IFN-α相关生长调节的选择性脱敏并不影响IFN-γ相关途径。我们的结果进一步支持了B16细胞中不同生长调节机制的共存,这些机制可被不同类型的干扰素彼此独立地激活。